Review article · 2023 · Open access
Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems
Pharmaceutics, 15(9), 2363 · Published 21 September 2023 · DOI 10.3390/pharmaceutics15092363
In brief
“Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems” is a 2023 review article by Cláudia Viegas and 6 co-authors, published in Pharmaceutics. OpenAlex counts 50 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Pharmaceutics.
- Citations
- 50
- Most cited in
- 2025 (22)
- Field-weighted impact
- 0.75
- References
- 200
- Authors
- 7
Abstract
Pancreatic cancer represents one of the most lethal cancer types worldwide, with a 5-year survival rate of less than 5%. Due to the inability to diagnose it promptly and the lack of efficacy of existing treatments, research and development of innovative therapies and new diagnostics are crucial to increase the survival rate and decrease mortality. Nanomedicine has been gaining importance as an innovative approach for drug delivery and diagnosis, opening new horizons through the implementation of smart nanocarrier systems, which can deliver drugs to the specific tissue or organ at an optimal concentration, enhancing treatment efficacy and reducing systemic toxicity. Varied materials such as lipids, polymers, and inorganic materials have been used to obtain nanoparticles and develop innovative drug delivery systems for pancreatic cancer treatment. In this review, it is discussed the main scientific advances in pancreatic cancer treatment by nano-based drug delivery systems. The advantages and disadvantages of such delivery systems in pancreatic cancer treatment are also addressed. More importantly, the different types of nanocarriers and therapeutic strategies developed so far are scrutinized.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Viegas, C., Patrício, A. B., Prata, J., Fonseca, L., Macedo, A. S., Duarte, S. O. D., & Fonte, P. (2023). Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems. Pharmaceutics, 15(9), 2363. https://doi.org/10.3390/pharmaceutics15092363
MLA 9
Viegas, Cláudia, et al. “Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems.” Pharmaceutics, vol. 15, no. 9, 2023, p. 2363. https://doi.org/10.3390/pharmaceutics15092363.
Chicago
Viegas, Cláudia, Ana B. Patrício, João Prata, Leonor Fonseca, Ana Sofia Macedo, Sofia O. D. Duarte, and Pedro Fonte. 2023. “Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems.” Pharmaceutics 15 (9): 2363. https://doi.org/10.3390/pharmaceutics15092363.
Harvard
Viegas, C. et al. (2023) ‘Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems’, Pharmaceutics, 15(9), p. 2363. doi:10.3390/pharmaceutics15092363.
IEEE
C. Viegas et al., “Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems,” Pharmaceutics, vol. 15, no. 9, p. 2363, 2023, doi: 10.3390/pharmaceutics15092363.
BibTeX
@article{viegas2023advances,
title = {{Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems}},
author = {Viegas, Cláudia and Patrício, Ana B. and Prata, João and Fonseca, Leonor and Macedo, Ana Sofia and Duarte, Sofia O. D. and Fonte, Pedro},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {9},
pages = {2363},
doi = {10.3390/pharmaceutics15092363},
url = {https://doi.org/10.3390/pharmaceutics15092363}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 2 | |
| 2024 | 11 | |
| 2025 | 22 | |
| 2026 | 15 |
Its field-weighted citation impact is 0.75: it has been cited 0.75 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pancreatic cancer
- nanoparticle drug delivery
- nanomedicine
- nanocarriers
- targeted drug delivery
- nanoparticles
- liposomes
- polymeric nanoparticles
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Viegas, C., Patrício, A. B., Prata, J., Fonseca, L., Macedo, A. S., Duarte, S. O. D., & Fonte, P. (2023). Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems. Pharmaceutics, 15(9), 2363. https://doi.org/10.3390/pharmaceutics15092363
How many times has this paper been cited?
50 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Pharmaceutics: sign in and open the PDF from this page.
Who wrote this paper?
Cláudia Viegas, Ana B. Patrício, João Prata, Leonor Fonseca, Ana Sofia Macedo, Sofia O. D. Duarte, Pedro Fonte.
What is the DOI of this paper?
10.3390/pharmaceutics15092363, permanently at https://doi.org/10.3390/pharmaceutics15092363. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.